Market Cap 5.47B
Revenue (ttm) 320.67M
Net Income (ttm) -289.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -90.38%
Debt to Equity Ratio 4.92
Volume 2,436,900
Avg Vol 3,107,606
Day's Range N/A - N/A
Shares Out 157.45M
Stochastic %K 34%
Beta N/A
Analysts Strong Sell
Price Target $58.55

Latest News on TEM

Tempus AI: Recent Weakness Presents Gift Ahead Of The Holidays

Dec 17, 2024, 10:42 PM EST - 4 weeks ago

Tempus AI: Recent Weakness Presents Gift Ahead Of The Holidays


Personalis and Tempus Expand Collaboration to Biopharma

Dec 16, 2024, 8:00 AM EST - 4 weeks ago

Personalis and Tempus Expand Collaboration to Biopharma

PSNL


Tempus AI: Why I'm Buying This AI Stock

Dec 8, 2024, 6:56 AM EST - 5 weeks ago

Tempus AI: Why I'm Buying This AI Stock


The Big 3: CRWD, CVNA, TEM

Nov 22, 2024, 12:14 PM EST - 2 months ago

The Big 3: CRWD, CVNA, TEM

CRWD CVNA


Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 5:10 AM EST - 2 months ago

Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript


Tempus: Attempting To Lead The AI Revolution In Healthcare

Oct 29, 2024, 1:47 PM EDT - 2 months ago

Tempus: Attempting To Lead The AI Revolution In Healthcare


Tempus Announces Real World Data Collaboration with BioNTech

Sep 4, 2024, 8:30 AM EDT - 4 months ago

Tempus Announces Real World Data Collaboration with BioNTech

BNTX


Personalis and Tempus Announce Expanded Collaboration

Aug 16, 2024, 8:30 AM EDT - 5 months ago

Personalis and Tempus Announce Expanded Collaboration

PSNL


Tempus Reports Second Quarter 2024 Results

Aug 6, 2024, 4:01 PM EDT - 5 months ago

Tempus Reports Second Quarter 2024 Results


Tempus Surpasses 500 Research Publications

Jul 10, 2024, 9:30 AM EDT - 6 months ago

Tempus Surpasses 500 Research Publications


Why Wall Street Is Bullish on Healthcare Tech Stock Tempus AI

Jul 9, 2024, 3:00 PM EDT - 6 months ago

Why Wall Street Is Bullish on Healthcare Tech Stock Tempus AI


TD Cowen's Dan Brennan on why he's bullish on Tempus

Jul 9, 2024, 2:23 PM EDT - 6 months ago

TD Cowen's Dan Brennan on why he's bullish on Tempus


Wall Street analysts bullish on genetic testing firm Tempus AI

Jul 9, 2024, 10:16 AM EDT - 6 months ago

Wall Street analysts bullish on genetic testing firm Tempus AI